Usefulness of transesophageal echocardiography to optimize treatment after ischemic stroke;Intérêt de l'échocardiographie trans- sophagienne dans l'optimisation de la stratégie thérapeutique après un accident vasculaire cérébral ischémique

Annales de Cardiologie et d'Angeiologie

Volumn 63, Issue 5, 2014, Pages 300-306

  Charbonnel, C ^a   Fanon, L ^a   Georges, J L ^a   Colonna, G ^a   Stefas, L ^a   Isorni, C ^a   Convers Domart, R ^a   Galuscan, G ^a   Baron, N ^a   Pico, F ^a   Livarek, B ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

Anti thrombotic therapy; Ischemic stroke; Multivessel territory acute ischemic stroke; Transesophageal echocardiography

Indexed keywords

AORTA ATHEROSCLEROSIS; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTRAST ECHOCARDIOGRAPHY; DECISIVE TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DISEASE ASSOCIATION; ENDOCARDITIS; EVALUATION STUDY; HEART ANEURYSM; HEART ATRIUM ENLARGEMENT; HEART ATRIUM THROMBOSIS; HEART RIGHT LEFT SHUNT; HUMAN; INFORMATIVE TRANSESOPHAGEAL ECHOCARDIOGRAPHY; LEFT ATRIAL DILATATION; MAJOR CLINICAL STUDY; MULTIVESSEL TERRITORY STROKE; PATENT FORAMEN OVALE; PHLEBITIS; PREDICTIVE VALUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 84908884667     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2014.08.001     Document Type: Article

References (29)

1. Ministère de la Santé. Les chiffres clés de l'accident vasculaire cérébral. http://www.sante.gouv.fr/les-chiffres-cles-de-l-avc.html.(accédé le 01/08/2014).
2. Bonita R. Epidemiology of stroke. Lancet 1992, 339:342-344.
3. Strandberg M., Marttila R.J., Helenius H., Hartiala J. Transoesophageal echocardiography should be considered in patients with ischaemic stroke or transient ischaemic attack. Clin Physiol Funct Imaging 2008, 28:156-160.
4. De Castro S., Papetti F., Di Angelantonio E., Razmovska B., Truscelli G., Tuderti U., et al. Feasibility and clinical utility of transesophageal echocardiography in the acute phase of cerebral ischemia. Am J Cardiol 2010, 106:1339-1344.
5. De Bruijn S.F.T.M., Agema W., Lammers G.J., van der Wall E.E., Wolterbeek R., Holman E.R., et al. Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke 2006, 37:2531-2534.
6. Harloff A., Handke M., Reinhard M., Geibel A., Hetzel A. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke 2006, 37:859-864.
7. Yaghoubi E., Nemati R., Aghasadeghi K., Borhani Haghighi A. The diagnostic efficiency of transesophageal compared to transthoracic echocardiographic findings from 405 patients with ischemic stroke. J Clin Neurosci 2011, 18:1486-1489.
8. European Stroke Organisation (ESO) Executive Committee Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis Basel Switz 2008, 25:457-507.
9. Adams H.P., del Zoppo G., Alberts M.J., Bhatt D.L., Brass L., Furlan A., et al. Guidelines for the early management of adults with ischemic stroke. Stroke 2007, 38:1655-1711.
10. Heidrich J., Heuschmann P.U., Kolominsky-Rabas P., Rudd A.G., Wolfe C.D.A. Variations in the use of diagnostic procedures after acute stroke in Europe: results from the BIOMED II study of stroke care. Eur J Neurol 2007, 14:255-261.
11. Meenan R.T., Saha S., Chou R., Swarztrauber K., Pyle Krages K., O'Keeffe-Rosetti M.C., et al. Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack. Med Decis Mak Int 2007, 27:161-177.
12. Hilberath J.N., Oakes D.A., Shernan S.K., Bulwer B.E., D'Ambra M.N., Eltzschig H.K. Safety of transesophageal echocardiography. J Am Soc Echocardiogr 2010, 23:1115-1127.
13. Flachskampf F.A., Badano L., Daniel W.G., Feneck R.O., Fox K.F., Fraser A.G., et al. Recommendations for transoesophageal echocardiography: update 2010. Eur J Echocardiogr 2010, 11:557-576.
14. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7:79-108.
15. Vahanian A., Alfieri O., Andreotti F., Antunes M.J., Barón-Esquivias G., Baumgartner H., et al. Guidelines on the management of valvular heart disease (version 2012). Eur J Cardio-Thorac Surg 2012, 42:S1-S44.
16. Cabanes L., Coste J., Derumeaux G., Jeanrenaud X., Lamy C., Zuber M., et al. Interobserver and intraobserver variability in detection of patent foramen ovale and atrial septal aneurysm with transesophageal echocardiography. J Am Soc Echocardiogr 2002, 15:441-446.
17. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
18. Hart R.G. Cardiogenic embolism to the brain. Lancet 1992, 339:589-594.
19. Leung D.Y., Black I.W., Cranney G.B., Hopkins A.P., Walsh W.F. Prognostic implications of left atrial spontaneous echo contrast in non-valvular atrial fibrillation. J Am Coll Cardiol 1994, 24:755-762.
20. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The stroke prevention in atrial fibrillation investigators committee on echocardiography. Ann Intern Med 1998, 128:639-647.
21. Ferrari E., Vidal R., Chevallier T., Baudouy M. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol 1999, 33:1317-1322.
22. Dressler F.A., Craig W.R., Castello R., Labovitz A.J. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998, 31:134-138.
23. Amarenco P., Davis S., Jones E.F., Cohen A.A., Heiss W.D., Kaste M., et al. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke 2014, 45(5):1248-1257.
24. Homma S., Sacco R.L., Di Tullio M.R., Sciacca R.R., Mohr J.P. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002, 105:2625-2631. PFO in Cryptogenic Stroke Study (PICSS) Investigators.
25. Carroll J.D., Saver J.L., Thaler D.E., Smalling R.W., Berry S., MacDonald L.A., et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. NEJM 2013, 368:1092-1100.
26. Furlan A.J., Reisman M., Massaro J., Mauri L., Adams H., Albers G.W., et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. NEJM 2012, 366:991-999.
27. Di Tullio M.R., Sacco R.L., Sciacca R.R., Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke 1999, 30:2019-2024.
28. Benjamin E.J., D'Agostino R.B., Belanger A.J., Wolf P.A., Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995, 92:835-841.
29. Ulrich J.N., Hesse B., Schuele S., Vlassak I., Sila C.A., Jaber W.A. Single-vessel versus multivessel territory acute ischemic stroke: value of transesophageal echocardiography in the differentiation of embolic stroke. J Am Soc Echocardiogr 2006, 19:1165-1169.